Keranova is entering the last phase that will lead to get market approval in 2022 for its robotic FemtoMatrix® surgical system
Ivantis® is the developer and manufacturer of the novel Hydrus® Microstent, a minimally-invasive glaucoma surgery (MIGS) device designed to lower...
This tool offers a breakthrough innovation to farmers and veterinarians, by making the diagnosis easier
Bylvay was approved in the US and the EU as the first drug for the treatment of pruritus in all types of PFIC
The partnership is set to reduce target discovery and validation from years down to months.
The agreement includes an option to license Xeris' suspension-based formulation technology, XeriJect.
Mablink and Emergence Therapeutics enter into a Licensing Agreement to develop antibody drug conjugate as a potential cancer therapy.
MxEP acts as lead investor in the $150 million growth financing, thus granting DentalMonitoring a well-deserved Unicorn status, as the second French...
GTP Nano leverages CEA's NanO'up R&D facility to validate an innovative manufacturing model and produce its first batches of drugs for precision...
